收费全文 | 28158篇 |
免费 | 2717篇 |
国内免费 | 472篇 |
耳鼻咽喉 | 95篇 |
儿科学 | 587篇 |
妇产科学 | 526篇 |
基础医学 | 2522篇 |
口腔科学 | 134篇 |
临床医学 | 3863篇 |
内科学 | 2230篇 |
皮肤病学 | 121篇 |
神经病学 | 9376篇 |
特种医学 | 218篇 |
外科学 | 1012篇 |
综合类 | 3274篇 |
现状与发展 | 2篇 |
一般理论 | 4篇 |
预防医学 | 1734篇 |
眼科学 | 110篇 |
药学 | 2958篇 |
35篇 | |
中国医学 | 1647篇 |
肿瘤学 | 899篇 |
2024年 | 115篇 |
2023年 | 529篇 |
2022年 | 788篇 |
2021年 | 1207篇 |
2020年 | 1243篇 |
2019年 | 1155篇 |
2018年 | 1119篇 |
2017年 | 1220篇 |
2016年 | 1256篇 |
2015年 | 1138篇 |
2014年 | 1872篇 |
2013年 | 2587篇 |
2012年 | 1664篇 |
2011年 | 1698篇 |
2010年 | 1485篇 |
2009年 | 1374篇 |
2008年 | 1375篇 |
2007年 | 1354篇 |
2006年 | 1166篇 |
2005年 | 969篇 |
2004年 | 788篇 |
2003年 | 740篇 |
2002年 | 639篇 |
2001年 | 486篇 |
2000年 | 357篇 |
1999年 | 263篇 |
1998年 | 255篇 |
1997年 | 280篇 |
1996年 | 203篇 |
1995年 | 183篇 |
1994年 | 196篇 |
1993年 | 146篇 |
1992年 | 171篇 |
1991年 | 132篇 |
1990年 | 106篇 |
1989年 | 125篇 |
1988年 | 117篇 |
1987年 | 125篇 |
1986年 | 95篇 |
1985年 | 123篇 |
1984年 | 90篇 |
1983年 | 66篇 |
1982年 | 69篇 |
1981年 | 59篇 |
1980年 | 48篇 |
1979年 | 36篇 |
1978年 | 28篇 |
1977年 | 30篇 |
1976年 | 26篇 |
1975年 | 19篇 |
Background
Refractory acute myeloid leukemia (AML) includes AML includes failure of disease to respond to standard induction chemotherapy, relapse within 6 months after first CR, and 2 or more relapses. The outcome of these patients is usually very poor; only a small proportion can be rescued by allogenic hematopoietic stem-cell transplantation (allo-HSCT). The aim of this study was to evaluate the efficacy and feasibility of allo-HSCT in patients with refractory AML.Patients and Methods
We retrospectively analyzed the clinical outcome of 91 patients who were diagnosed with treatment-refractory AML at Hacettepe University Hospital between January 2002 and June 2018. Patients' disease status included refractory AML, defined as failure to respond to standard induction chemotherapy and relapse within 6 months after first complete remission.Results
The median follow-up was 12 months (range, 0.5-184 months) for the entire group. Kaplan-Meier estimates of the 3-year overall survival for patients who underwent allo-HSCT and patients who received only salvage chemotherapy were 67% and 12%, respectively. Additionally, the Kaplan-Meier estimates of 5-year overall survival for patients who underwent allo-HSCT and patients who received only salvage chemotherapy were 44% and 4%, respectively (P < .001). Complete remission was obtained in 25 patients (83.3%) who underwent allo-HSCT; however, the disease of only 3 patients (3.8%) exhibited complete response after salvage chemotherapy.Conclusion
Allo-HSCT is still the best-known treatment option with curative potential in patients with treatment-refractory AML. Therefore, all efforts should be made in an attempt to find a suitable matched donor in order to perform allo-HSCT. 相似文献Method: This is a randomized study registered in Chinese Clinical Trial Registry (ChiCTR-IOR-17011289). Eighty rural left-behind elderly people who had a Geriatric Depression Scale (GDS) score between 11 and 25 were randomly assigned to the intervention (n?=?40) and control group (n?=?40). The intervention group received both MBAT and regular treatment for 8 weeks while the control group received regular treatment. Both groups were assessed with the GDS, Beck Anxiety Inventory (BAI), and Oxford Happiness Questionnaire (OHQ) at baseline, immediately post-intervention, and at 3 months post-intervention.
Results: There were a total of 73 participants that completed the intervention. The scores of GDS and BAI decreased significantly, but the scores of OHQ increased significantly in the intervention group after 8 sessions of MBAT (P?<?.01). The reduction in depression symptoms after the intervention was maintained at the 3-month follow-up. Significant differences in GDS, BAI, and OHQ scores were observed between the intervention group and the control group (P?<?.01).
Conclusion: MBAT produced a significantly greater reduction in depressive symptoms than regular care in rural left-behind elderly.
Clinical or methodological significance of this article: A modified behavioral activation (BA) psychotherapy can significantly reduce the recurrence and seriousness of depression symptoms in the left-behind elderly with mild to moderate depression. This study also suggests that further study of the MBAT as an intervention will provide a direction for the management of mental health in rural left-behind elders. 相似文献